Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Hsien Hong Lin"'
Publikováno v:
Journal of Engineering, Project, and Production Management, Vol 12, Iss 3, Pp 209-216 (2022)
Assigning the right member to the most suitable position is key to the success of a project, and this task has been commonly executed by the project manager based on personal judgment in practice. This paper proposes a matching approach coupled with
Externí odkaz:
https://doaj.org/article/279867832ff540408bf77bd44788afb7
Publikováno v:
Applied Artificial Intelligence, Vol 36, Iss 1 (2022)
Enterprises analyze opportunities and threats in the external environment, measure internal strengths and weaknesses, and formulate strategic objectives to stay ahead of their opponents. Product portfolio management (PPM) is a dynamic process by whic
Externí odkaz:
https://doaj.org/article/aceb7aade18941e69130d0e19ce0866c
Autor:
Hsien‐Hong Lin, Shih‐Jer Hsu, Sheng‐Nan Lu, Wan‐Long Chuang, Chao‐Wei Hsu, Rong‐Nan Chien, Sien‐Sing Yang, Wei‐Wen Su, Jaw‐Ching Wu, Tzong‐Hsi Lee, Cheng‐Yuan Peng, Kuan‐Chiao Tseng, Albert Qin, Yi‐Wen Huang, Pei‐Jer Chen
Publikováno v:
JGH Open, Vol 5, Iss 8, Pp 929-940 (2021)
ABSTRACT Background and Aim Ropeginterferon alfa‐2b (P1101) is a novel long‐acting mono‐PEGylated recombinant proline interferon (IFN) conjugated to a 40 kDa branched polyethylene glycol (PEG) chain at its N‐terminus, allowing every‐two‐w
Externí odkaz:
https://doaj.org/article/d99d520d83e548769c19cb86c1436144
Autor:
Shih-Jer Hsu, Ming-Lung Yu, Chien-Wei Su, Cheng-Yuan Peng, Rong-Nan Chien, Hsien-Hong Lin, Gin-Ho Lo, Wei-Wen Su, Hsing-Tao Kuo, Chao-Wei Hsu, Sien-Sing Yang, Sheng-Shun Yang, Kuan-Chiao Tseng, Albert Qin, Yi-Wen Huang, Wan-Long Chuang
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 3, Pp 956-964 (2021)
Background: Ropeginterferon alfa-2b is a novel mono-pegylated interferon that has only one major form as opposed to the 8 to 14 isomers of other on-market pegylated interferon products, allowing every-two-week injection with high tolerability. It rec
Externí odkaz:
https://doaj.org/article/4401340d479a46a9a34dc86614b2c302
Publikováno v:
Engineering Economics. 33:386-397
This paper proposes an approach to select a market segment portfolio to maximize overall profit. The study first uses artificial intelligence algorithms to select the market segments with high profitability. The mathematical programming model is then
Publikováno v:
Concurrent Engineering. 30:382-398
Most enterprises focus on product portfolio management (PPM) and exclude market portfolio management, and individual markets are selected solely based on financial performance which may not be appropriate because other factors may dictate the outcome
Publikováno v:
Cybernetics and Systems. 53:298-317
Autor:
Chao Wei Hsu, Chien Wei Su, Ming-Lung Yu, Sien-Sing Yang, Shih Jer Hsu, Hsing Tao Kuo, Albert Qin, Gin Ho Lo, Yi Wen Huang, Sheng-Shun Yang, Wan-Long Chuang, Hsien Hong Lin, Rong-Nan Chien, Wei Wen Su, Cheng Yuan Peng, Kuan-Chiao Tseng
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 3, Pp 956-964 (2021)
Background Ropeginterferon alfa-2b is a novel mono-pegylated interferon that has only one major form as opposed to the 8 to 14 isomers of other on-market pegylated interferon products, allowing every-two-week injection with high tolerability. It rece
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 21, Iss 7, Pp 299-303 (2005)
Esophageal acid exposure is common in normal subjects. The aim of this study was to investigate proximal and distal esophageal acid exposure in asymptomatic volunteers using dual-channel esophageal pH-metry with probe positioning by pH step-up. A tot
Externí odkaz:
https://doaj.org/article/446a09ae5dcf46808ea9d4c4c45cdfb6
Autor:
Cheng Yuan Peng, Chao Wei Hsu, Rong-Nan Chien, Hsien Hong Lin, Kuan-Chiao Tseng, Sheng Nan Lu, Jaw Ching Wu, Albert Qin, Pei-Jer Chen, Yi Wen Huang, Shih Jer Hsu, Wei Wen Su, Wan-Long Chuang, Tzong Hsi Lee, Sien-Sing Yang
Publikováno v:
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
JGH Open, Vol 5, Iss 8, Pp 929-940 (2021)
JGH Open, Vol 5, Iss 8, Pp 929-940 (2021)
Background and Aim Ropeginterferon alfa‐2b (P1101) is a novel long‐acting mono‐PEGylated recombinant proline interferon (IFN) conjugated to a 40 kDa branched polyethylene glycol (PEG) chain at its N‐terminus, allowing every‐two‐week injec